Medical Care
DNA Diagnostics & Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Sep 11, 24
- ID: 549923
- Pages: 107
- Figures: 187
- Views: 2
The global market for DNA Diagnostics & Testing was estimated to be worth US$ 10260 million in 2023 and is forecast to a readjusted size of US$ 10120 million by 2030 with a CAGR of -0.2% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for DNA Diagnostics & Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of DNA Diagnostics & Testing by region & country, by Type, and by Application.
The DNA Diagnostics & Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA Diagnostics & Testing.
Market Segmentation
By Company
Abbott Laboratories
Affymetrix Inc.
Agilent Technologies Inc
Applied Biosystems Group
Illumina Inc.
Cepheid Inc.
Hologic
Bio-Rad Laboratories
Dako
Abbott
Roche Diagnostics
Beckman Coulter Inc.
Siemens Healthcare
Segment by Type:
PCR Based Diagnostics
NGS DNA Diagnosis
In-situ Hybridization Diagnostics
Micro-arrays Based Diagnostics
Segment by Application
Oncology Diagnostics & Histopathology
Identity Diagnostics & Forensics
Pharmacogenomics Diagnostic Testing & Drug Metabolism
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of DNA Diagnostics & Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of DNA Diagnostics & Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of DNA Diagnostics & Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for DNA Diagnostics & Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of DNA Diagnostics & Testing by region & country, by Type, and by Application.
The DNA Diagnostics & Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA Diagnostics & Testing.
Market Segmentation
By Company
Abbott Laboratories
Affymetrix Inc.
Agilent Technologies Inc
Applied Biosystems Group
Illumina Inc.
Cepheid Inc.
Hologic
Bio-Rad Laboratories
Dako
Abbott
Roche Diagnostics
Beckman Coulter Inc.
Siemens Healthcare
Segment by Type:
PCR Based Diagnostics
NGS DNA Diagnosis
In-situ Hybridization Diagnostics
Micro-arrays Based Diagnostics
Segment by Application
Oncology Diagnostics & Histopathology
Identity Diagnostics & Forensics
Pharmacogenomics Diagnostic Testing & Drug Metabolism
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of DNA Diagnostics & Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of DNA Diagnostics & Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of DNA Diagnostics & Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 DNA Diagnostics & Testing Product Introduction
1.2 Global DNA Diagnostics & Testing Market Size Forecast
1.3 DNA Diagnostics & Testing Market Trends & Drivers
1.3.1 DNA Diagnostics & Testing Industry Trends
1.3.2 DNA Diagnostics & Testing Market Drivers & Opportunity
1.3.3 DNA Diagnostics & Testing Market Challenges
1.3.4 DNA Diagnostics & Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global DNA Diagnostics & Testing Players Revenue Ranking (2023)
2.2 Global DNA Diagnostics & Testing Revenue by Company (2019-2024)
2.3 Key Companies DNA Diagnostics & Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies DNA Diagnostics & Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of DNA Diagnostics & Testing
2.6 DNA Diagnostics & Testing Market Competitive Analysis
2.6.1 DNA Diagnostics & Testing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by DNA Diagnostics & Testing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Diagnostics & Testing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 PCR Based Diagnostics
3.1.2 NGS DNA Diagnosis
3.1.3 In-situ Hybridization Diagnostics
3.1.4 Micro-arrays Based Diagnostics
3.2 Global DNA Diagnostics & Testing Sales Value by Type
3.2.1 Global DNA Diagnostics & Testing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global DNA Diagnostics & Testing Sales Value, by Type (2019-2030)
3.2.3 Global DNA Diagnostics & Testing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Oncology Diagnostics & Histopathology
4.1.2 Identity Diagnostics & Forensics
4.1.3 Pharmacogenomics Diagnostic Testing & Drug Metabolism
4.2 Global DNA Diagnostics & Testing Sales Value by Application
4.2.1 Global DNA Diagnostics & Testing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global DNA Diagnostics & Testing Sales Value, by Application (2019-2030)
4.2.3 Global DNA Diagnostics & Testing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global DNA Diagnostics & Testing Sales Value by Region
5.1.1 Global DNA Diagnostics & Testing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global DNA Diagnostics & Testing Sales Value by Region (2019-2024)
5.1.3 Global DNA Diagnostics & Testing Sales Value by Region (2025-2030)
5.1.4 Global DNA Diagnostics & Testing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America DNA Diagnostics & Testing Sales Value, 2019-2030
5.2.2 North America DNA Diagnostics & Testing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe DNA Diagnostics & Testing Sales Value, 2019-2030
5.3.2 Europe DNA Diagnostics & Testing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific DNA Diagnostics & Testing Sales Value, 2019-2030
5.4.2 Asia Pacific DNA Diagnostics & Testing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America DNA Diagnostics & Testing Sales Value, 2019-2030
5.5.2 South America DNA Diagnostics & Testing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa DNA Diagnostics & Testing Sales Value, 2019-2030
5.6.2 Middle East & Africa DNA Diagnostics & Testing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions DNA Diagnostics & Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions DNA Diagnostics & Testing Sales Value
6.3 United States
6.3.1 United States DNA Diagnostics & Testing Sales Value, 2019-2030
6.3.2 United States DNA Diagnostics & Testing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States DNA Diagnostics & Testing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe DNA Diagnostics & Testing Sales Value, 2019-2030
6.4.2 Europe DNA Diagnostics & Testing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe DNA Diagnostics & Testing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China DNA Diagnostics & Testing Sales Value, 2019-2030
6.5.2 China DNA Diagnostics & Testing Sales Value by Type (%), 2023 VS 2030
6.5.3 China DNA Diagnostics & Testing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan DNA Diagnostics & Testing Sales Value, 2019-2030
6.6.2 Japan DNA Diagnostics & Testing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan DNA Diagnostics & Testing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea DNA Diagnostics & Testing Sales Value, 2019-2030
6.7.2 South Korea DNA Diagnostics & Testing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea DNA Diagnostics & Testing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia DNA Diagnostics & Testing Sales Value, 2019-2030
6.8.2 Southeast Asia DNA Diagnostics & Testing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia DNA Diagnostics & Testing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India DNA Diagnostics & Testing Sales Value, 2019-2030
6.9.2 India DNA Diagnostics & Testing Sales Value by Type (%), 2023 VS 2030
6.9.3 India DNA Diagnostics & Testing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Profile
7.1.2 Abbott Laboratories Main Business
7.1.3 Abbott Laboratories DNA Diagnostics & Testing Products, Services and Solutions
7.1.4 Abbott Laboratories DNA Diagnostics & Testing Revenue (US$ Million) & (2019-2024)
7.1.5 Abbott Laboratories Recent Developments
7.2 Affymetrix Inc.
7.2.1 Affymetrix Inc. Profile
7.2.2 Affymetrix Inc. Main Business
7.2.3 Affymetrix Inc. DNA Diagnostics & Testing Products, Services and Solutions
7.2.4 Affymetrix Inc. DNA Diagnostics & Testing Revenue (US$ Million) & (2019-2024)
7.2.5 Affymetrix Inc. Recent Developments
7.3 Agilent Technologies Inc
7.3.1 Agilent Technologies Inc Profile
7.3.2 Agilent Technologies Inc Main Business
7.3.3 Agilent Technologies Inc DNA Diagnostics & Testing Products, Services and Solutions
7.3.4 Agilent Technologies Inc DNA Diagnostics & Testing Revenue (US$ Million) & (2019-2024)
7.3.5 Applied Biosystems Group Recent Developments
7.4 Applied Biosystems Group
7.4.1 Applied Biosystems Group Profile
7.4.2 Applied Biosystems Group Main Business
7.4.3 Applied Biosystems Group DNA Diagnostics & Testing Products, Services and Solutions
7.4.4 Applied Biosystems Group DNA Diagnostics & Testing Revenue (US$ Million) & (2019-2024)
7.4.5 Applied Biosystems Group Recent Developments
7.5 Illumina Inc.
7.5.1 Illumina Inc. Profile
7.5.2 Illumina Inc. Main Business
7.5.3 Illumina Inc. DNA Diagnostics & Testing Products, Services and Solutions
7.5.4 Illumina Inc. DNA Diagnostics & Testing Revenue (US$ Million) & (2019-2024)
7.5.5 Illumina Inc. Recent Developments
7.6 Cepheid Inc.
7.6.1 Cepheid Inc. Profile
7.6.2 Cepheid Inc. Main Business
7.6.3 Cepheid Inc. DNA Diagnostics & Testing Products, Services and Solutions
7.6.4 Cepheid Inc. DNA Diagnostics & Testing Revenue (US$ Million) & (2019-2024)
7.6.5 Cepheid Inc. Recent Developments
7.7 Hologic
7.7.1 Hologic Profile
7.7.2 Hologic Main Business
7.7.3 Hologic DNA Diagnostics & Testing Products, Services and Solutions
7.7.4 Hologic DNA Diagnostics & Testing Revenue (US$ Million) & (2019-2024)
7.7.5 Hologic Recent Developments
7.8 Bio-Rad Laboratories
7.8.1 Bio-Rad Laboratories Profile
7.8.2 Bio-Rad Laboratories Main Business
7.8.3 Bio-Rad Laboratories DNA Diagnostics & Testing Products, Services and Solutions
7.8.4 Bio-Rad Laboratories DNA Diagnostics & Testing Revenue (US$ Million) & (2019-2024)
7.8.5 Bio-Rad Laboratories Recent Developments
7.9 Dako
7.9.1 Dako Profile
7.9.2 Dako Main Business
7.9.3 Dako DNA Diagnostics & Testing Products, Services and Solutions
7.9.4 Dako DNA Diagnostics & Testing Revenue (US$ Million) & (2019-2024)
7.9.5 Dako Recent Developments
7.10 Abbott
7.10.1 Abbott Profile
7.10.2 Abbott Main Business
7.10.3 Abbott DNA Diagnostics & Testing Products, Services and Solutions
7.10.4 Abbott DNA Diagnostics & Testing Revenue (US$ Million) & (2019-2024)
7.10.5 Abbott Recent Developments
7.11 Roche Diagnostics
7.11.1 Roche Diagnostics Profile
7.11.2 Roche Diagnostics Main Business
7.11.3 Roche Diagnostics DNA Diagnostics & Testing Products, Services and Solutions
7.11.4 Roche Diagnostics DNA Diagnostics & Testing Revenue (US$ Million) & (2019-2024)
7.11.5 Roche Diagnostics Recent Developments
7.12 Beckman Coulter Inc.
7.12.1 Beckman Coulter Inc. Profile
7.12.2 Beckman Coulter Inc. Main Business
7.12.3 Beckman Coulter Inc. DNA Diagnostics & Testing Products, Services and Solutions
7.12.4 Beckman Coulter Inc. DNA Diagnostics & Testing Revenue (US$ Million) & (2019-2024)
7.12.5 Beckman Coulter Inc. Recent Developments
7.13 Siemens Healthcare
7.13.1 Siemens Healthcare Profile
7.13.2 Siemens Healthcare Main Business
7.13.3 Siemens Healthcare DNA Diagnostics & Testing Products, Services and Solutions
7.13.4 Siemens Healthcare DNA Diagnostics & Testing Revenue (US$ Million) & (2019-2024)
7.13.5 Siemens Healthcare Recent Developments
8 Industry Chain Analysis
8.1 DNA Diagnostics & Testing Industrial Chain
8.2 DNA Diagnostics & Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 DNA Diagnostics & Testing Sales Model
8.5.2 Sales Channel
8.5.3 DNA Diagnostics & Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 DNA Diagnostics & Testing Product Introduction
1.2 Global DNA Diagnostics & Testing Market Size Forecast
1.3 DNA Diagnostics & Testing Market Trends & Drivers
1.3.1 DNA Diagnostics & Testing Industry Trends
1.3.2 DNA Diagnostics & Testing Market Drivers & Opportunity
1.3.3 DNA Diagnostics & Testing Market Challenges
1.3.4 DNA Diagnostics & Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global DNA Diagnostics & Testing Players Revenue Ranking (2023)
2.2 Global DNA Diagnostics & Testing Revenue by Company (2019-2024)
2.3 Key Companies DNA Diagnostics & Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies DNA Diagnostics & Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of DNA Diagnostics & Testing
2.6 DNA Diagnostics & Testing Market Competitive Analysis
2.6.1 DNA Diagnostics & Testing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by DNA Diagnostics & Testing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Diagnostics & Testing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 PCR Based Diagnostics
3.1.2 NGS DNA Diagnosis
3.1.3 In-situ Hybridization Diagnostics
3.1.4 Micro-arrays Based Diagnostics
3.2 Global DNA Diagnostics & Testing Sales Value by Type
3.2.1 Global DNA Diagnostics & Testing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global DNA Diagnostics & Testing Sales Value, by Type (2019-2030)
3.2.3 Global DNA Diagnostics & Testing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Oncology Diagnostics & Histopathology
4.1.2 Identity Diagnostics & Forensics
4.1.3 Pharmacogenomics Diagnostic Testing & Drug Metabolism
4.2 Global DNA Diagnostics & Testing Sales Value by Application
4.2.1 Global DNA Diagnostics & Testing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global DNA Diagnostics & Testing Sales Value, by Application (2019-2030)
4.2.3 Global DNA Diagnostics & Testing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global DNA Diagnostics & Testing Sales Value by Region
5.1.1 Global DNA Diagnostics & Testing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global DNA Diagnostics & Testing Sales Value by Region (2019-2024)
5.1.3 Global DNA Diagnostics & Testing Sales Value by Region (2025-2030)
5.1.4 Global DNA Diagnostics & Testing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America DNA Diagnostics & Testing Sales Value, 2019-2030
5.2.2 North America DNA Diagnostics & Testing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe DNA Diagnostics & Testing Sales Value, 2019-2030
5.3.2 Europe DNA Diagnostics & Testing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific DNA Diagnostics & Testing Sales Value, 2019-2030
5.4.2 Asia Pacific DNA Diagnostics & Testing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America DNA Diagnostics & Testing Sales Value, 2019-2030
5.5.2 South America DNA Diagnostics & Testing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa DNA Diagnostics & Testing Sales Value, 2019-2030
5.6.2 Middle East & Africa DNA Diagnostics & Testing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions DNA Diagnostics & Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions DNA Diagnostics & Testing Sales Value
6.3 United States
6.3.1 United States DNA Diagnostics & Testing Sales Value, 2019-2030
6.3.2 United States DNA Diagnostics & Testing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States DNA Diagnostics & Testing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe DNA Diagnostics & Testing Sales Value, 2019-2030
6.4.2 Europe DNA Diagnostics & Testing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe DNA Diagnostics & Testing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China DNA Diagnostics & Testing Sales Value, 2019-2030
6.5.2 China DNA Diagnostics & Testing Sales Value by Type (%), 2023 VS 2030
6.5.3 China DNA Diagnostics & Testing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan DNA Diagnostics & Testing Sales Value, 2019-2030
6.6.2 Japan DNA Diagnostics & Testing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan DNA Diagnostics & Testing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea DNA Diagnostics & Testing Sales Value, 2019-2030
6.7.2 South Korea DNA Diagnostics & Testing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea DNA Diagnostics & Testing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia DNA Diagnostics & Testing Sales Value, 2019-2030
6.8.2 Southeast Asia DNA Diagnostics & Testing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia DNA Diagnostics & Testing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India DNA Diagnostics & Testing Sales Value, 2019-2030
6.9.2 India DNA Diagnostics & Testing Sales Value by Type (%), 2023 VS 2030
6.9.3 India DNA Diagnostics & Testing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Profile
7.1.2 Abbott Laboratories Main Business
7.1.3 Abbott Laboratories DNA Diagnostics & Testing Products, Services and Solutions
7.1.4 Abbott Laboratories DNA Diagnostics & Testing Revenue (US$ Million) & (2019-2024)
7.1.5 Abbott Laboratories Recent Developments
7.2 Affymetrix Inc.
7.2.1 Affymetrix Inc. Profile
7.2.2 Affymetrix Inc. Main Business
7.2.3 Affymetrix Inc. DNA Diagnostics & Testing Products, Services and Solutions
7.2.4 Affymetrix Inc. DNA Diagnostics & Testing Revenue (US$ Million) & (2019-2024)
7.2.5 Affymetrix Inc. Recent Developments
7.3 Agilent Technologies Inc
7.3.1 Agilent Technologies Inc Profile
7.3.2 Agilent Technologies Inc Main Business
7.3.3 Agilent Technologies Inc DNA Diagnostics & Testing Products, Services and Solutions
7.3.4 Agilent Technologies Inc DNA Diagnostics & Testing Revenue (US$ Million) & (2019-2024)
7.3.5 Applied Biosystems Group Recent Developments
7.4 Applied Biosystems Group
7.4.1 Applied Biosystems Group Profile
7.4.2 Applied Biosystems Group Main Business
7.4.3 Applied Biosystems Group DNA Diagnostics & Testing Products, Services and Solutions
7.4.4 Applied Biosystems Group DNA Diagnostics & Testing Revenue (US$ Million) & (2019-2024)
7.4.5 Applied Biosystems Group Recent Developments
7.5 Illumina Inc.
7.5.1 Illumina Inc. Profile
7.5.2 Illumina Inc. Main Business
7.5.3 Illumina Inc. DNA Diagnostics & Testing Products, Services and Solutions
7.5.4 Illumina Inc. DNA Diagnostics & Testing Revenue (US$ Million) & (2019-2024)
7.5.5 Illumina Inc. Recent Developments
7.6 Cepheid Inc.
7.6.1 Cepheid Inc. Profile
7.6.2 Cepheid Inc. Main Business
7.6.3 Cepheid Inc. DNA Diagnostics & Testing Products, Services and Solutions
7.6.4 Cepheid Inc. DNA Diagnostics & Testing Revenue (US$ Million) & (2019-2024)
7.6.5 Cepheid Inc. Recent Developments
7.7 Hologic
7.7.1 Hologic Profile
7.7.2 Hologic Main Business
7.7.3 Hologic DNA Diagnostics & Testing Products, Services and Solutions
7.7.4 Hologic DNA Diagnostics & Testing Revenue (US$ Million) & (2019-2024)
7.7.5 Hologic Recent Developments
7.8 Bio-Rad Laboratories
7.8.1 Bio-Rad Laboratories Profile
7.8.2 Bio-Rad Laboratories Main Business
7.8.3 Bio-Rad Laboratories DNA Diagnostics & Testing Products, Services and Solutions
7.8.4 Bio-Rad Laboratories DNA Diagnostics & Testing Revenue (US$ Million) & (2019-2024)
7.8.5 Bio-Rad Laboratories Recent Developments
7.9 Dako
7.9.1 Dako Profile
7.9.2 Dako Main Business
7.9.3 Dako DNA Diagnostics & Testing Products, Services and Solutions
7.9.4 Dako DNA Diagnostics & Testing Revenue (US$ Million) & (2019-2024)
7.9.5 Dako Recent Developments
7.10 Abbott
7.10.1 Abbott Profile
7.10.2 Abbott Main Business
7.10.3 Abbott DNA Diagnostics & Testing Products, Services and Solutions
7.10.4 Abbott DNA Diagnostics & Testing Revenue (US$ Million) & (2019-2024)
7.10.5 Abbott Recent Developments
7.11 Roche Diagnostics
7.11.1 Roche Diagnostics Profile
7.11.2 Roche Diagnostics Main Business
7.11.3 Roche Diagnostics DNA Diagnostics & Testing Products, Services and Solutions
7.11.4 Roche Diagnostics DNA Diagnostics & Testing Revenue (US$ Million) & (2019-2024)
7.11.5 Roche Diagnostics Recent Developments
7.12 Beckman Coulter Inc.
7.12.1 Beckman Coulter Inc. Profile
7.12.2 Beckman Coulter Inc. Main Business
7.12.3 Beckman Coulter Inc. DNA Diagnostics & Testing Products, Services and Solutions
7.12.4 Beckman Coulter Inc. DNA Diagnostics & Testing Revenue (US$ Million) & (2019-2024)
7.12.5 Beckman Coulter Inc. Recent Developments
7.13 Siemens Healthcare
7.13.1 Siemens Healthcare Profile
7.13.2 Siemens Healthcare Main Business
7.13.3 Siemens Healthcare DNA Diagnostics & Testing Products, Services and Solutions
7.13.4 Siemens Healthcare DNA Diagnostics & Testing Revenue (US$ Million) & (2019-2024)
7.13.5 Siemens Healthcare Recent Developments
8 Industry Chain Analysis
8.1 DNA Diagnostics & Testing Industrial Chain
8.2 DNA Diagnostics & Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 DNA Diagnostics & Testing Sales Model
8.5.2 Sales Channel
8.5.3 DNA Diagnostics & Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. DNA Diagnostics & Testing Market Trends
Table 2. DNA Diagnostics & Testing Market Drivers & Opportunity
Table 3. DNA Diagnostics & Testing Market Challenges
Table 4. DNA Diagnostics & Testing Market Restraints
Table 5. Global DNA Diagnostics & Testing Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global DNA Diagnostics & Testing Revenue Market Share by Company (2019-2024)
Table 7. Key Companies DNA Diagnostics & Testing Manufacturing Base Distribution and Headquarters
Table 8. Key Companies DNA Diagnostics & Testing Product Type
Table 9. Key Companies Time to Begin Mass Production of DNA Diagnostics & Testing
Table 10. Global DNA Diagnostics & Testing Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Diagnostics & Testing as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global DNA Diagnostics & Testing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global DNA Diagnostics & Testing Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global DNA Diagnostics & Testing Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global DNA Diagnostics & Testing Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global DNA Diagnostics & Testing Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global DNA Diagnostics & Testing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global DNA Diagnostics & Testing Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global DNA Diagnostics & Testing Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global DNA Diagnostics & Testing Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global DNA Diagnostics & Testing Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global DNA Diagnostics & Testing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global DNA Diagnostics & Testing Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global DNA Diagnostics & Testing Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global DNA Diagnostics & Testing Sales Value by Region (2019-2024) & (%)
Table 27. Global DNA Diagnostics & Testing Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions DNA Diagnostics & Testing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions DNA Diagnostics & Testing Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions DNA Diagnostics & Testing Sales Value, (2025-2030) & (US$ Million)
Table 31. Abbott Laboratories Basic Information List
Table 32. Abbott Laboratories Description and Business Overview
Table 33. Abbott Laboratories DNA Diagnostics & Testing Products, Services and Solutions
Table 34. Revenue (US$ Million) in DNA Diagnostics & Testing Business of Abbott Laboratories (2019-2024)
Table 35. Abbott Laboratories Recent Developments
Table 36. Affymetrix Inc. Basic Information List
Table 37. Affymetrix Inc. Description and Business Overview
Table 38. Affymetrix Inc. DNA Diagnostics & Testing Products, Services and Solutions
Table 39. Revenue (US$ Million) in DNA Diagnostics & Testing Business of Affymetrix Inc. (2019-2024)
Table 40. Affymetrix Inc. Recent Developments
Table 41. Agilent Technologies Inc Basic Information List
Table 42. Agilent Technologies Inc Description and Business Overview
Table 43. Agilent Technologies Inc DNA Diagnostics & Testing Products, Services and Solutions
Table 44. Revenue (US$ Million) in DNA Diagnostics & Testing Business of Agilent Technologies Inc (2019-2024)
Table 45. Agilent Technologies Inc Recent Developments
Table 46. Applied Biosystems Group Basic Information List
Table 47. Applied Biosystems Group Description and Business Overview
Table 48. Applied Biosystems Group DNA Diagnostics & Testing Products, Services and Solutions
Table 49. Revenue (US$ Million) in DNA Diagnostics & Testing Business of Applied Biosystems Group (2019-2024)
Table 50. Applied Biosystems Group Recent Developments
Table 51. Illumina Inc. Basic Information List
Table 52. Illumina Inc. Description and Business Overview
Table 53. Illumina Inc. DNA Diagnostics & Testing Products, Services and Solutions
Table 54. Revenue (US$ Million) in DNA Diagnostics & Testing Business of Illumina Inc. (2019-2024)
Table 55. Illumina Inc. Recent Developments
Table 56. Cepheid Inc. Basic Information List
Table 57. Cepheid Inc. Description and Business Overview
Table 58. Cepheid Inc. DNA Diagnostics & Testing Products, Services and Solutions
Table 59. Revenue (US$ Million) in DNA Diagnostics & Testing Business of Cepheid Inc. (2019-2024)
Table 60. Cepheid Inc. Recent Developments
Table 61. Hologic Basic Information List
Table 62. Hologic Description and Business Overview
Table 63. Hologic DNA Diagnostics & Testing Products, Services and Solutions
Table 64. Revenue (US$ Million) in DNA Diagnostics & Testing Business of Hologic (2019-2024)
Table 65. Hologic Recent Developments
Table 66. Bio-Rad Laboratories Basic Information List
Table 67. Bio-Rad Laboratories Description and Business Overview
Table 68. Bio-Rad Laboratories DNA Diagnostics & Testing Products, Services and Solutions
Table 69. Revenue (US$ Million) in DNA Diagnostics & Testing Business of Bio-Rad Laboratories (2019-2024)
Table 70. Bio-Rad Laboratories Recent Developments
Table 71. Dako Basic Information List
Table 72. Dako Description and Business Overview
Table 73. Dako DNA Diagnostics & Testing Products, Services and Solutions
Table 74. Revenue (US$ Million) in DNA Diagnostics & Testing Business of Dako (2019-2024)
Table 75. Dako Recent Developments
Table 76. Abbott Basic Information List
Table 77. Abbott Description and Business Overview
Table 78. Abbott DNA Diagnostics & Testing Products, Services and Solutions
Table 79. Revenue (US$ Million) in DNA Diagnostics & Testing Business of Abbott (2019-2024)
Table 80. Abbott Recent Developments
Table 81. Roche Diagnostics Basic Information List
Table 82. Roche Diagnostics Description and Business Overview
Table 83. Roche Diagnostics DNA Diagnostics & Testing Products, Services and Solutions
Table 84. Revenue (US$ Million) in DNA Diagnostics & Testing Business of Roche Diagnostics (2019-2024)
Table 85. Roche Diagnostics Recent Developments
Table 86. Beckman Coulter Inc. Basic Information List
Table 87. Beckman Coulter Inc. Description and Business Overview
Table 88. Beckman Coulter Inc. DNA Diagnostics & Testing Products, Services and Solutions
Table 89. Revenue (US$ Million) in DNA Diagnostics & Testing Business of Beckman Coulter Inc. (2019-2024)
Table 90. Beckman Coulter Inc. Recent Developments
Table 91. Siemens Healthcare Basic Information List
Table 92. Siemens Healthcare Description and Business Overview
Table 93. Siemens Healthcare DNA Diagnostics & Testing Products, Services and Solutions
Table 94. Revenue (US$ Million) in DNA Diagnostics & Testing Business of Siemens Healthcare (2019-2024)
Table 95. Siemens Healthcare Recent Developments
Table 96. Key Raw Materials Lists
Table 97. Raw Materials Key Suppliers Lists
Table 98. DNA Diagnostics & Testing Downstream Customers
Table 99. DNA Diagnostics & Testing Distributors List
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. DNA Diagnostics & Testing Product Picture
Figure 2. Global DNA Diagnostics & Testing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global DNA Diagnostics & Testing Sales Value (2019-2030) & (US$ Million)
Figure 4. DNA Diagnostics & Testing Report Years Considered
Figure 5. Global DNA Diagnostics & Testing Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by DNA Diagnostics & Testing Revenue in 2023
Figure 7. DNA Diagnostics & Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. PCR Based Diagnostics Picture
Figure 9. NGS DNA Diagnosis Picture
Figure 10. In-situ Hybridization Diagnostics Picture
Figure 11. Micro-arrays Based Diagnostics Picture
Figure 12. Global DNA Diagnostics & Testing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global DNA Diagnostics & Testing Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Oncology Diagnostics & Histopathology
Figure 15. Product Picture of Identity Diagnostics & Forensics
Figure 16. Product Picture of Pharmacogenomics Diagnostic Testing & Drug Metabolism
Figure 17. Global DNA Diagnostics & Testing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global DNA Diagnostics & Testing Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America DNA Diagnostics & Testing Sales Value (2019-2030) & (US$ Million)
Figure 20. North America DNA Diagnostics & Testing Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe DNA Diagnostics & Testing Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe DNA Diagnostics & Testing Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific DNA Diagnostics & Testing Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific DNA Diagnostics & Testing Sales Value by Country (%), 2023 VS 2030
Figure 25. South America DNA Diagnostics & Testing Sales Value (2019-2030) & (US$ Million)
Figure 26. South America DNA Diagnostics & Testing Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa DNA Diagnostics & Testing Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa DNA Diagnostics & Testing Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions DNA Diagnostics & Testing Sales Value (%), (2019-2030)
Figure 30. United States DNA Diagnostics & Testing Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States DNA Diagnostics & Testing Sales Value by Type (%), 2023 VS 2030
Figure 32. United States DNA Diagnostics & Testing Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe DNA Diagnostics & Testing Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe DNA Diagnostics & Testing Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe DNA Diagnostics & Testing Sales Value by Application (%), 2023 VS 2030
Figure 36. China DNA Diagnostics & Testing Sales Value, (2019-2030) & (US$ Million)
Figure 37. China DNA Diagnostics & Testing Sales Value by Type (%), 2023 VS 2030
Figure 38. China DNA Diagnostics & Testing Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan DNA Diagnostics & Testing Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan DNA Diagnostics & Testing Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan DNA Diagnostics & Testing Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea DNA Diagnostics & Testing Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea DNA Diagnostics & Testing Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea DNA Diagnostics & Testing Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia DNA Diagnostics & Testing Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia DNA Diagnostics & Testing Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia DNA Diagnostics & Testing Sales Value by Application (%), 2023 VS 2030
Figure 48. India DNA Diagnostics & Testing Sales Value, (2019-2030) & (US$ Million)
Figure 49. India DNA Diagnostics & Testing Sales Value by Type (%), 2023 VS 2030
Figure 50. India DNA Diagnostics & Testing Sales Value by Application (%), 2023 VS 2030
Figure 51. DNA Diagnostics & Testing Industrial Chain
Figure 52. DNA Diagnostics & Testing Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Table 1. DNA Diagnostics & Testing Market Trends
Table 2. DNA Diagnostics & Testing Market Drivers & Opportunity
Table 3. DNA Diagnostics & Testing Market Challenges
Table 4. DNA Diagnostics & Testing Market Restraints
Table 5. Global DNA Diagnostics & Testing Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global DNA Diagnostics & Testing Revenue Market Share by Company (2019-2024)
Table 7. Key Companies DNA Diagnostics & Testing Manufacturing Base Distribution and Headquarters
Table 8. Key Companies DNA Diagnostics & Testing Product Type
Table 9. Key Companies Time to Begin Mass Production of DNA Diagnostics & Testing
Table 10. Global DNA Diagnostics & Testing Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Diagnostics & Testing as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global DNA Diagnostics & Testing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global DNA Diagnostics & Testing Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global DNA Diagnostics & Testing Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global DNA Diagnostics & Testing Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global DNA Diagnostics & Testing Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global DNA Diagnostics & Testing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global DNA Diagnostics & Testing Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global DNA Diagnostics & Testing Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global DNA Diagnostics & Testing Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global DNA Diagnostics & Testing Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global DNA Diagnostics & Testing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global DNA Diagnostics & Testing Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global DNA Diagnostics & Testing Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global DNA Diagnostics & Testing Sales Value by Region (2019-2024) & (%)
Table 27. Global DNA Diagnostics & Testing Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions DNA Diagnostics & Testing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions DNA Diagnostics & Testing Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions DNA Diagnostics & Testing Sales Value, (2025-2030) & (US$ Million)
Table 31. Abbott Laboratories Basic Information List
Table 32. Abbott Laboratories Description and Business Overview
Table 33. Abbott Laboratories DNA Diagnostics & Testing Products, Services and Solutions
Table 34. Revenue (US$ Million) in DNA Diagnostics & Testing Business of Abbott Laboratories (2019-2024)
Table 35. Abbott Laboratories Recent Developments
Table 36. Affymetrix Inc. Basic Information List
Table 37. Affymetrix Inc. Description and Business Overview
Table 38. Affymetrix Inc. DNA Diagnostics & Testing Products, Services and Solutions
Table 39. Revenue (US$ Million) in DNA Diagnostics & Testing Business of Affymetrix Inc. (2019-2024)
Table 40. Affymetrix Inc. Recent Developments
Table 41. Agilent Technologies Inc Basic Information List
Table 42. Agilent Technologies Inc Description and Business Overview
Table 43. Agilent Technologies Inc DNA Diagnostics & Testing Products, Services and Solutions
Table 44. Revenue (US$ Million) in DNA Diagnostics & Testing Business of Agilent Technologies Inc (2019-2024)
Table 45. Agilent Technologies Inc Recent Developments
Table 46. Applied Biosystems Group Basic Information List
Table 47. Applied Biosystems Group Description and Business Overview
Table 48. Applied Biosystems Group DNA Diagnostics & Testing Products, Services and Solutions
Table 49. Revenue (US$ Million) in DNA Diagnostics & Testing Business of Applied Biosystems Group (2019-2024)
Table 50. Applied Biosystems Group Recent Developments
Table 51. Illumina Inc. Basic Information List
Table 52. Illumina Inc. Description and Business Overview
Table 53. Illumina Inc. DNA Diagnostics & Testing Products, Services and Solutions
Table 54. Revenue (US$ Million) in DNA Diagnostics & Testing Business of Illumina Inc. (2019-2024)
Table 55. Illumina Inc. Recent Developments
Table 56. Cepheid Inc. Basic Information List
Table 57. Cepheid Inc. Description and Business Overview
Table 58. Cepheid Inc. DNA Diagnostics & Testing Products, Services and Solutions
Table 59. Revenue (US$ Million) in DNA Diagnostics & Testing Business of Cepheid Inc. (2019-2024)
Table 60. Cepheid Inc. Recent Developments
Table 61. Hologic Basic Information List
Table 62. Hologic Description and Business Overview
Table 63. Hologic DNA Diagnostics & Testing Products, Services and Solutions
Table 64. Revenue (US$ Million) in DNA Diagnostics & Testing Business of Hologic (2019-2024)
Table 65. Hologic Recent Developments
Table 66. Bio-Rad Laboratories Basic Information List
Table 67. Bio-Rad Laboratories Description and Business Overview
Table 68. Bio-Rad Laboratories DNA Diagnostics & Testing Products, Services and Solutions
Table 69. Revenue (US$ Million) in DNA Diagnostics & Testing Business of Bio-Rad Laboratories (2019-2024)
Table 70. Bio-Rad Laboratories Recent Developments
Table 71. Dako Basic Information List
Table 72. Dako Description and Business Overview
Table 73. Dako DNA Diagnostics & Testing Products, Services and Solutions
Table 74. Revenue (US$ Million) in DNA Diagnostics & Testing Business of Dako (2019-2024)
Table 75. Dako Recent Developments
Table 76. Abbott Basic Information List
Table 77. Abbott Description and Business Overview
Table 78. Abbott DNA Diagnostics & Testing Products, Services and Solutions
Table 79. Revenue (US$ Million) in DNA Diagnostics & Testing Business of Abbott (2019-2024)
Table 80. Abbott Recent Developments
Table 81. Roche Diagnostics Basic Information List
Table 82. Roche Diagnostics Description and Business Overview
Table 83. Roche Diagnostics DNA Diagnostics & Testing Products, Services and Solutions
Table 84. Revenue (US$ Million) in DNA Diagnostics & Testing Business of Roche Diagnostics (2019-2024)
Table 85. Roche Diagnostics Recent Developments
Table 86. Beckman Coulter Inc. Basic Information List
Table 87. Beckman Coulter Inc. Description and Business Overview
Table 88. Beckman Coulter Inc. DNA Diagnostics & Testing Products, Services and Solutions
Table 89. Revenue (US$ Million) in DNA Diagnostics & Testing Business of Beckman Coulter Inc. (2019-2024)
Table 90. Beckman Coulter Inc. Recent Developments
Table 91. Siemens Healthcare Basic Information List
Table 92. Siemens Healthcare Description and Business Overview
Table 93. Siemens Healthcare DNA Diagnostics & Testing Products, Services and Solutions
Table 94. Revenue (US$ Million) in DNA Diagnostics & Testing Business of Siemens Healthcare (2019-2024)
Table 95. Siemens Healthcare Recent Developments
Table 96. Key Raw Materials Lists
Table 97. Raw Materials Key Suppliers Lists
Table 98. DNA Diagnostics & Testing Downstream Customers
Table 99. DNA Diagnostics & Testing Distributors List
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. DNA Diagnostics & Testing Product Picture
Figure 2. Global DNA Diagnostics & Testing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global DNA Diagnostics & Testing Sales Value (2019-2030) & (US$ Million)
Figure 4. DNA Diagnostics & Testing Report Years Considered
Figure 5. Global DNA Diagnostics & Testing Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by DNA Diagnostics & Testing Revenue in 2023
Figure 7. DNA Diagnostics & Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. PCR Based Diagnostics Picture
Figure 9. NGS DNA Diagnosis Picture
Figure 10. In-situ Hybridization Diagnostics Picture
Figure 11. Micro-arrays Based Diagnostics Picture
Figure 12. Global DNA Diagnostics & Testing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global DNA Diagnostics & Testing Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Oncology Diagnostics & Histopathology
Figure 15. Product Picture of Identity Diagnostics & Forensics
Figure 16. Product Picture of Pharmacogenomics Diagnostic Testing & Drug Metabolism
Figure 17. Global DNA Diagnostics & Testing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global DNA Diagnostics & Testing Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America DNA Diagnostics & Testing Sales Value (2019-2030) & (US$ Million)
Figure 20. North America DNA Diagnostics & Testing Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe DNA Diagnostics & Testing Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe DNA Diagnostics & Testing Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific DNA Diagnostics & Testing Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific DNA Diagnostics & Testing Sales Value by Country (%), 2023 VS 2030
Figure 25. South America DNA Diagnostics & Testing Sales Value (2019-2030) & (US$ Million)
Figure 26. South America DNA Diagnostics & Testing Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa DNA Diagnostics & Testing Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa DNA Diagnostics & Testing Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions DNA Diagnostics & Testing Sales Value (%), (2019-2030)
Figure 30. United States DNA Diagnostics & Testing Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States DNA Diagnostics & Testing Sales Value by Type (%), 2023 VS 2030
Figure 32. United States DNA Diagnostics & Testing Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe DNA Diagnostics & Testing Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe DNA Diagnostics & Testing Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe DNA Diagnostics & Testing Sales Value by Application (%), 2023 VS 2030
Figure 36. China DNA Diagnostics & Testing Sales Value, (2019-2030) & (US$ Million)
Figure 37. China DNA Diagnostics & Testing Sales Value by Type (%), 2023 VS 2030
Figure 38. China DNA Diagnostics & Testing Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan DNA Diagnostics & Testing Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan DNA Diagnostics & Testing Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan DNA Diagnostics & Testing Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea DNA Diagnostics & Testing Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea DNA Diagnostics & Testing Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea DNA Diagnostics & Testing Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia DNA Diagnostics & Testing Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia DNA Diagnostics & Testing Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia DNA Diagnostics & Testing Sales Value by Application (%), 2023 VS 2030
Figure 48. India DNA Diagnostics & Testing Sales Value, (2019-2030) & (US$ Million)
Figure 49. India DNA Diagnostics & Testing Sales Value by Type (%), 2023 VS 2030
Figure 50. India DNA Diagnostics & Testing Sales Value by Application (%), 2023 VS 2030
Figure 51. DNA Diagnostics & Testing Industrial Chain
Figure 52. DNA Diagnostics & Testing Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232